EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alport Syndrome: Clinical Utility of Early Genetic Diagnosis in Children

Vasileia Christodoulaki, Konstantina Kosma, Nikolaos M Marinakis iD, Faidon-Nikolaos Tilemis iD, Nikolaos Stergiou, Afroditi Kampouraki iD, Charalampos Kapogiannis iD, Vasiliki Karava iD, Andromachi Mitsioni, Maria Mila, Christina Kanaka-Gantenbein iD, Periklis Makrythanasis und 2 weitere

Genes · 02.08.2024 · 15 (8) · 1016

DOI: 10.3390/genes15081016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 02.08.2024. Verfasst von Vasileia Christodoulaki und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Genetics, Medical School, National and Kapodistrian University of Athens (NKUA), 11527 Athens, Greece. Hauptthemen laut MEDLINE: Nephritis, Hereditary. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alport syndrome (AS) is a hereditary glomerulopathy due to pathogenic variants in COL4A3, COL4A4, and COL4A5. Treatment with Renin–Angiotensin–Aldosterone System (RAAS) inhibitors can delay progression to end stage renal disease (ESRD). From 2018 until today, we performed Whole Exome Sequencing (WES) in 19 patients with AS phenotype with or without positive family history. Fourteen of these patients were children. Genetic testing was extended to family members at risk. All patients received a genetic diagnosis of AS: five X-linked AS (XLAS) males, five X-linked AS (XLAS) females, six autosomal dominant AS (ADAS), and one autosomal recessive AS (ARAS). After cascade screening four XLAS males and eight XLAS females, six ADAS and three ARAS heterozygotes were added to our initial results. Fifteen patients were eligible to start treatment with RAAS inhibitors after their diagnosis. All XLAS female patients, ARAS heterozygotes, and ADAS have been advised to be followed up, so that therapeutic intervention can begin in the presence of microalbuminuria. Genetic diagnosis of AS ensures early therapeutic intervention and appropriate follow up to delay progression to chronic kidney disease, especially in thet pediatric population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephritis, HereditaryHumansFemaleMaleChildChild, PreschoolAdolescentGenetic TestingExome SequencingCollagen Type IVEarly DiagnosisInfantMutationAdultKidney Failure, ChronicPhenotype

Stichwörter der Autor:innen

Alport syndromeCOL4A3COL4A4COL4A5RAAS inhibitorscascade screeningchildren

Substanzen

Collagen Type IVCOL4A5 protein, humanCOL4A4 protein, human

Autor:innen und Institutionen

  • Laboratory of Medical Genetics, Medical School, National and Kapodistrian University of Athens (NKUA), 11527 Athens, Greece.
  • First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, "Aghia Sophia" Children's Hospital, 11527 Athens, Greece.
  • University Research Institute for the Study and Treatment of Genetic and Malignant Disorders in Childhood, Aghia Sophia Children's Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Department of Nephrology, "P. and A. Kyriakou" Children's Hospital, 11527 Athens, Greece.
  • Division of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics, Medical School, Aghia Sophia Children's Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.

ORCID-Profile: Nikolaos M Marinakis, Faidon-Nikolaos Tilemis, Afroditi Kampouraki, Charalampos Kapogiannis, Vasiliki Karava, Christina Kanaka-Gantenbein, Maria Tzetis, Joanne Traeger-Synodinos

Zitieren

APA

Christodoulaki, V., Kosma, K., Marinakis, N. M., Tilemis, F. N., Stergiou, N., Kampouraki, A., Kapogiannis, C., Karava, V., Mitsioni, A., Mila, M., Kanaka-Gantenbein, C., Makrythanasis, P., Tzetis, M., & Traeger-Synodinos, J. (2024). Alport Syndrome: Clinical Utility of Early Genetic Diagnosis in Children. Genes, 15(8), 1016. https://doi.org/10.3390/genes15081016

Vancouver

Christodoulaki V, Kosma K, Marinakis NM, Tilemis FN, Stergiou N, Kampouraki A, et al. Alport Syndrome: Clinical Utility of Early Genetic Diagnosis in Children. Genes. 2024;15(8):1016. doi:10.3390/genes15081016

BibTeX
@article{Christodoulaki2024,
  author = {Christodoulaki, Vasileia and Kosma, Konstantina and Marinakis, Nikolaos M and Tilemis, Faidon-Nikolaos and Stergiou, Nikolaos and Kampouraki, Afroditi and Kapogiannis, Charalampos and Karava, Vasiliki and Mitsioni, Andromachi and Mila, Maria and Kanaka-Gantenbein, Christina and Makrythanasis, Periklis and Tzetis, Maria and Traeger-Synodinos, Joanne},
  title = {Alport Syndrome: Clinical Utility of Early Genetic Diagnosis in Children},
  journal = {Genes},
  year = {2024},
  volume = {15},
  number = {8},
  pages = {1016},
  doi = {10.3390/genes15081016}
}
Kostenlos starten →